Platform·Energy/Renewable Energy·June 15, 2026
Prime Radiant Partners acquires Cellares
The platform investment centers on a company specializing in automated cell therapy manufacturing, with transaction terms undisclosed in the announcement.
Takeaways
- Prime Radiant Partners is acquiring Cellares.
- Disclosed scale includes $50M.
BuyerPrime Radiant Partners
TargetCellares
SponsorPrime Radiant Partners
TypePlatform
IndustryEnergy
Sub-sectorRenewable Energy
Prime Radiant Partners invested $50 million in Cellares, a company specializing in automated cell therapy manufacturing.
The investment gives Prime Radiant exposure to a biomanufacturing platform focused on scaling cell therapy production.
Terms beyond the disclosed investment amount were not provided.
Daily PE deal brief
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.